Primary immunodeficiencies underlying fungal infections

Purpose of reviewWe review the primary immunodeficiencies (PIDs) underlying an increasing variety of superficial and invasive fungal infections. We also stress that the occurrence of such fungal infections should lead physicians to search for the corresponding single-gene inborn errors of immunity. Finally, we suggest that other fungal infections may also result from hitherto unknown inborn errors of immunity, at least in some patients with no known risk factors. Recent findingsAn increasing number of PIDs are being shown to underlie fungal infectious diseases in children and young adults. Inborn errors of the phagocyte NADPH oxidase complex (chronic granulomatous disease), severe congenital neutropenia (SCN) and leukocyte adhesion deficiency type I confer a predisposition to invasive aspergillosis and candidiasis. More rarely, inborn errors of interferon-&ggr; immunity underlie endemic mycoses. Inborn errors of interleukin-17 immunity have recently been shown to underlie chronic mucocutaneous candidiasis (CMC), while inborn errors of caspase recruitment domain-containing protein 9 (CARD9) immunity underlie deep dermatophytosis and invasive candidiasis. SummaryCMC, invasive candidiasis, invasive aspergillosis, deep dermatophytosis, pneumocystosis, and endemic mycoses can all be caused by PIDs. Each type of infection is highly suggestive of a specific type of PID. In the absence of overt risk factors, single-gene inborn errors of immunity should be sought in children and young adults with these and other fungal diseases.

[1]  R. Hay,et al.  Deep dermatophytosis and inherited CARD9 deficiency. , 2013, The New England journal of medicine.

[2]  J. Casanova,et al.  The genetic theory of infectious diseases: a brief history and selected illustrations. , 2013, Annual review of genomics and human genetics.

[3]  Amos Etzioni,et al.  Continuous G-CSF therapy for isolated chronic mucocutaneous candidiasis: complete clinical remission with restoration of IL-17 secretion. , 2013, The Journal of allergy and clinical immunology.

[4]  S. Holland,et al.  MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  T. Kuijpers,et al.  Cutaneous manifestations of primary immunodeficiency , 2013, Current opinion in pediatrics.

[6]  B. Grimbacher,et al.  Autosomal dominant cases of chronic mucocutaneous candidiasis segregates with mutations of signal transducer and activator of transcription 1, but not of Toll-like receptor 3. , 2013, The Journal of pediatrics.

[7]  H. Turki,et al.  Fusarioses diagnostiquées au laboratoire d’un CHU en Tunisie : étude épidémiologique, clinique et mycologique , 2013 .

[8]  S. Holland,et al.  Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival. , 2013, The Journal of allergy and clinical immunology.

[9]  S. Holland,et al.  Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. , 2013, The Journal of allergy and clinical immunology.

[10]  J. Ruland,et al.  Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation. , 2013, Trends in immunology.

[11]  J. Yim,et al.  Immune deficiencies, infection, and systemic immune disordersDominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation–polyendocrinopathy–enteropathy–X-linked–like syndrome , 2013 .

[12]  T. Hökfelt,et al.  A Novel Gain-of-Function IKBA Mutation Underlies Ectodermal Dysplasia with Immunodeficiency and Polyendocrinopathy , 2013, Journal of Clinical Immunology.

[13]  J. Casanova,et al.  New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe , 2013, Journal of Medical Genetics.

[14]  T. Rausch,et al.  Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency. , 2013, The Journal of allergy and clinical immunology.

[15]  S. Smeekens,et al.  Genetic susceptibility to Candida infections , 2013, EMBO molecular medicine.

[16]  S. Holland,et al.  Anti–GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis , 2013, The Journal of Immunology.

[17]  Z. Wan,et al.  Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis. , 2013, The Journal of allergy and clinical immunology.

[18]  C. de Beaufort,et al.  Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. , 2013, Blood.

[19]  Sami Al-Hajjar,et al.  Inherited IL-12p40 Deficiency , 2013, Medicine.

[20]  J. Casanova,et al.  Autoantibodies against cytokines: back to human genetics. , 2013, Blood.

[21]  Chi-Yuan Li,et al.  Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. , 2013, Blood.

[22]  J. Casanova,et al.  Primary immunodeficiencies: a rapidly evolving story. , 2013, The Journal of allergy and clinical immunology.

[23]  Anne-Kathrin Kienzler,et al.  Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. , 2013, The Journal of allergy and clinical immunology.

[24]  A. Weyrich,et al.  Lessons from rare maladies: leukocyte adhesion deficiency syndromes , 2012, Current opinion in hematology.

[25]  A. Ayadi,et al.  [Fusariosis diagnosed in the laboratory of an UH in Tunisia: epidemiological, clinical and mycological study]. , 2013, Journal de mycologie medicale.

[26]  S. Ranque,et al.  The efficacy of voriconazole in 24 ocular Fusarium infections , 2013, Infection.

[27]  David W. Denning,et al.  Hidden Killers: Human Fungal Infections , 2012, Science Translational Medicine.

[28]  Salvador Nkondjo Minkoumou,et al.  Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients , 2012, International journal of dermatology.

[29]  S. Holland,et al.  Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management , 2012, Current opinion in infectious diseases.

[30]  J. Casanova,et al.  Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis , 2012, Current opinion in allergy and clinical immunology.

[31]  T. Wright,et al.  Pneumocystis: Where Does It Live? , 2012, PLoS pathogens.

[32]  J. Casanova,et al.  Immunity to infection in IL‐17‐deficient mice and humans , 2012, European journal of immunology.

[33]  Gordon D. Brown,et al.  C-type lectin receptors orchestrate antifungal immunity , 2012, Nature Immunology.

[34]  A. Fischer,et al.  Inherited MST1 Deficiency Underlies Susceptibility to EV-HPV Infections , 2012, PloS one.

[35]  Smita Y. Patel,et al.  Adult-onset immunodeficiency in Thailand and Taiwan. , 2012, The New England journal of medicine.

[36]  O. Ohara,et al.  Chronic Mucocutaneous Candidiasis Caused by a Gain-of-Function Mutation in the STAT1 DNA-Binding Domain , 2012, The Journal of Immunology.

[37]  D. Lilić Unravelling fungal immunity through primary immune deficiencies. , 2012, Current opinion in microbiology.

[38]  Y. Hirose,et al.  Autosomal-Dominant Chronic Mucocutaneous Candidiasis with STAT1-Mutation can be Complicated with Chronic Active Hepatitis and Hypothyroidism , 2012, Journal of Clinical Immunology.

[39]  A. Fischer,et al.  Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey , 2012, Medicine.

[40]  J. Casanova,et al.  Herpes in STAT1 gain-of-function mutation , 2012, The Lancet.

[41]  L. Wheat,et al.  Endemic mycoses: overlooked causes of community acquired pneumonia. , 2012, Respiratory medicine.

[42]  J. Casanova,et al.  Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes , 2012, Current Opinion in Immunology.

[43]  S. Gaffen,et al.  Th17 cells in immunity to Candida albicans. , 2012, Cell host & microbe.

[44]  A. Casadevall,et al.  Review Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases , 2022 .

[45]  D. Denning,et al.  Tackling Human Fungal Infections , 2012, Science.

[46]  J. Casanova,et al.  Inborn errors of human JAKs and STATs. , 2012, Immunity.

[47]  D. MacCallum,et al.  C-type lectin receptors and cytokines in fungal immunity. , 2012, Cytokine.

[48]  A. Morris,et al.  Colonization by Pneumocystis jirovecii and Its Role in Disease , 2012, Clinical Microbiology Reviews.

[49]  C. Reis e Sousa,et al.  Signaling by myeloid C-type lectin receptors in immunity and homeostasis. , 2012, Annual review of immunology.

[50]  K. Honma,et al.  GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia , 2012, European Journal of Pediatrics.

[51]  R. Alam,et al.  A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. , 2012, Blood.

[52]  H. Urlaub,et al.  Syk Kinase-Coupled C-type Lectin Receptors Engage Protein Kinase C-δ to Elicit Card9 Adaptor-Mediated Innate Immunity , 2012, Immunity.

[53]  A. Schäffer,et al.  The phenotype of human STK4 deficiency. , 2011, Blood.

[54]  T. Hohl,et al.  Immunity to fungi. , 2012, Current opinion in immunology.

[55]  A. Schäffer,et al.  The phenotype of human STK 4 deficiency , 2012 .

[56]  M. Lionakis Genetic Susceptibility to Fungal Infections in Humans , 2012, Current Fungal Infection Reports.

[57]  A. Fischer,et al.  Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[58]  A. Hoischen,et al.  STAT1 Hyperphosphorylation and Defective IL12R/IL23R Signaling Underlie Defective Immunity in Autosomal Dominant Chronic Mucocutaneous Candidiasis , 2011, PloS one.

[59]  H. Su,et al.  DOCK8 deficiency , 2011, Annals of the New York Academy of Sciences.

[60]  B. Lebeau,et al.  Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[61]  H. Tcheurekdjian,et al.  Histoplasmosis in the olecranon bursa of a patient with idiopathic CD4 lymphocytopenia. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[62]  A. Chakrabarti,et al.  The emerging epidemiology of mould infections in developing countries , 2011, Current opinion in infectious diseases.

[63]  J. Puck Neonatal screening for severe combined immunodeficiency , 2011, Current opinion in pediatrics.

[64]  A. Fischer,et al.  Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. , 2011, Blood.

[65]  F. Queiroz-Telles,et al.  Epidemiology of endemic systemic fungal infections in Latin America. , 2011, Medical mycology.

[66]  D. Vinh Insights into human antifungal immunity from primary immunodeficiencies. , 2011, The Lancet. Infectious diseases.

[67]  Smita Y. Patel,et al.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. , 2011, Blood.

[68]  A. Dutra,et al.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications , 2011, Haematologica.

[69]  A. Fischer,et al.  Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.

[70]  D. Douek,et al.  Second messenger role for Mg2+ revealed by human T-cell immunodeficiency , 2011, Nature.

[71]  A. Hoischen,et al.  STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. , 2011, The New England journal of medicine.

[72]  J. Casanova,et al.  Infectious Diseases in Patients with IRAK-4, MyD88, NEMO, or IκBα Deficiency , 2011, Clinical Microbiology Reviews.

[73]  M. van der Burg,et al.  Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. , 2011, Blood.

[74]  C. Bodemer,et al.  Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity , 2011, Science.

[75]  Gordon D. Brown,et al.  Syk-coupled C-type lectins in immunity , 2011, Trends in immunology.

[76]  D. O’Brien,et al.  Candida infection of the central nervous system following neurosurgery: a 12-year review , 2011, Acta Neurochirurgica.

[77]  Gordon D. Brown Innate antifungal immunity: the key role of phagocytes. , 2011, Annual review of immunology.

[78]  J. Casanova,et al.  Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease , 2011, Nature Immunology.

[79]  S. Pittaluga,et al.  Interleukin-12 receptor β1 deficiency predisposing to disseminated Coccidioidomycosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[80]  N. McGovern,et al.  The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency , 2011, The Journal of experimental medicine.

[81]  W. Tate,et al.  Mutation in the TCRα subunit constant gene (TRAC) leads to a human immunodeficiency disorder characterized by a lack of TCRαβ+ T cells. , 2011, The Journal of clinical investigation.

[82]  A. Fischer,et al.  Epidemiology and Outcome of Invasive Fungal Diseases in Patients With Chronic Granulomatous Disease: A Multicenter Study in France , 2011, The Pediatric infectious disease journal.

[83]  Y. Iwakura,et al.  The role of Syk/CARD9 coupled C-type lectins in antifungal immunity , 2010, European journal of immunology.

[84]  J. Stockman,et al.  Combined Immunodeficiency Associated with DOCK8 Mutations , 2011 .

[85]  R. Panush Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2011 .

[86]  E. Dei‐Cas,et al.  Pneumocystis jirovecii Pneumonia , 2011 .

[87]  S. Holland,et al.  Residual NADPH oxidase and survival in chronic granulomatous disease. , 2010, The New England journal of medicine.

[88]  Smita Y. Patel,et al.  Revisiting Human IL-12R&bgr;1 Deficiency: A Survey of 141 Patients From 30 Countries , 2010, Medicine.

[89]  H. Ochs,et al.  Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.

[90]  J. Casanova,et al.  Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? , 2010, Current opinion in immunology.

[91]  S. Holland,et al.  Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. , 2010, The Journal of allergy and clinical immunology.

[92]  D. Scott‐Algara,et al.  Idiopathic CD4 (cid:1) T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4 , 2009 .

[93]  A. Fischer,et al.  Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency. , 2010, Immunology and allergy clinics of North America.

[94]  D. Hospenthal,et al.  Disseminated dermatophytosis in a patient with hereditary hemochromatosis and hepatic cirrhosis: case report and review of the literature. , 2010, Medical mycology.

[95]  A. Ayadi,et al.  La maladie dermatophytique: revue de la littérature , 2010 .

[96]  H. Turki,et al.  Un cas de maladie dermatophytique fatale par abcès rétropharyngé , 2010 .

[97]  Adeline R. Whitney,et al.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. , 2010, Blood.

[98]  F. Cetani,et al.  Abbreviations used: AD, , 2022 .

[99]  A. Fischer,et al.  Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2010, The Journal of experimental medicine.

[100]  A. Schäffer,et al.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. , 2010, The Journal of allergy and clinical immunology.

[101]  Aseem Kumar,et al.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) , 2010 .

[102]  A. Ayadi,et al.  [A fatal case of dermatomycoses with retropharyngeal abscess]. , 2010, Annales de dermatologie et de venereologie.

[103]  S. Sinha,et al.  Disseminated histoplasmosis as the first presentation of idiopathic CD4+ T-lymphocytopenia. , 2010, Journal of postgraduate medicine.

[104]  S. Holland,et al.  Combined immunodeficiency associated with DOCK8 mutations. , 2009, The New England journal of medicine.

[105]  Edward R B McCabe,et al.  Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. , 2009, The Journal of allergy and clinical immunology.

[106]  A. Schäffer,et al.  A homozygous CARD9 mutation in a family with susceptibility to fungal infections. , 2009, The New England journal of medicine.

[107]  Xing Jun Li,et al.  A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. , 2009, Blood.

[108]  S. Holland,et al.  Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  J. Casanova,et al.  Human genetics of infectious diseases: between proof of principle and paradigm. , 2009, The Journal of clinical investigation.

[110]  S. Elliott,et al.  The spectrum and presentation of disseminated coccidioidomycosis. , 2009, The American journal of medicine.

[111]  H. Takada,et al.  Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome , 2009, The Journal of experimental medicine.

[112]  H. Hara,et al.  CARD9 versus CARMA1 in innate and adaptive immunity. , 2009, Trends in immunology.

[113]  François Gouin,et al.  Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) , 2009, Critical care medicine.

[114]  C. Lass‐Flörl The changing face of epidemiology of invasive fungal disease in Europe , 2009, Mycoses.

[115]  Dirk Roos,et al.  Chronic Granulomatous Disease: The European Experience , 2009, PloS one.

[116]  K. Wannemuehler,et al.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS , 2009, AIDS.

[117]  J. Kere,et al.  Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. , 2008, Molecular immunology.

[118]  Philippe Lutun,et al.  Factors associated with overall and attributable mortality in invasive aspergillosis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  J. Penninger,et al.  Cell Type-Specific Regulation of ITAM-Mediated NF-κB Activation by the Adaptors, CARMA1 and CARD91 , 2008, The Journal of Immunology.

[120]  J. Metcalf,et al.  Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. , 2008, Blood.

[121]  A. Fischer,et al.  Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells , 2008, The Journal of experimental medicine.

[122]  S. Tangye,et al.  Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 , 2008, The Journal of experimental medicine.

[123]  M. Leppert,et al.  Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. , 2008, The Journal of allergy and clinical immunology.

[124]  J. Bouchara,et al.  Updates on the Epidemiology of Dermatophyte Infections , 2008, Mycopathologia.

[125]  W. Paul,et al.  Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome , 2008, Nature.

[126]  G. Galbraith Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome , 2008 .

[127]  S. Tangye,et al.  Defi ciency of Th 17 cells in hyper IgE syndrome due to mutations in STAT 3 Cindy , 2008 .

[128]  J. Metcalf,et al.  Idiopathic CD4 (cid:1) lymphocytopenia: natural history and prognostic factors , 2008 .

[129]  H. Karasuyama,et al.  Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiency , 2007, Current opinion in allergy and clinical immunology.

[130]  Bodo Grimbacher,et al.  STAT3 mutations in the hyper-IgE syndrome. , 2007, The New England journal of medicine.

[131]  D. Levy,et al.  IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways , 2007, Nature Immunology.

[132]  J. Casanova,et al.  Primary Immunodeficiencies: A Field in Its Infancy , 2007, Science.

[133]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[134]  J. Penninger,et al.  The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors , 2007, Nature Immunology.

[135]  J. Falloon,et al.  Cryptococcosis and Idiopathic CD4 Lymphocytopenia , 2007, Medicine.

[136]  A. Caudy,et al.  CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. , 2007, The Journal of allergy and clinical immunology.

[137]  X. Qin,et al.  The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens , 2007, Nature Immunology.

[138]  S. Mathoulin-Pélissier,et al.  Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study , 2007, PLoS medicine.

[139]  C. Kauffman Histoplasmosis: a Clinical and Laboratory Update , 2007, Clinical Microbiology Reviews.

[140]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[141]  O. B. Stambouli,et al.  CA17 - La teigne : un mode de début de la maladie dermatophytique , 2007 .

[142]  Bengt Fadeel,et al.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) , 2007, Nature Genetics.

[143]  J. Ruland,et al.  Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity , 2006, Nature.

[144]  J. Casanova,et al.  Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease , 2006, PLoS genetics.

[145]  M. Gershwin,et al.  Current Perspectives on Primary Immunodeficiency Diseases , 2006, Clinical & developmental immunology.

[146]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[147]  Bogdan Tanasa,et al.  A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function , 2006, Nature.

[148]  S. Holland,et al.  Immunotherapy for fungal infections. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[149]  William Oh,et al.  Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months , 2006, Pediatrics.

[150]  L. Notarangelo,et al.  Immunodeficiencies with autoimmune consequences. , 2006, Advances in immunology.

[151]  T. Tejasvi,et al.  Invasive dermatophytosis with lymph node involvement in an immunocompetent patient , 2005, Clinical and experimental dermatology.

[152]  S. Holland,et al.  Disseminated Histoplasmosis in Persons with Interferon-γ Receptor 1 Deficiency , 2005 .

[153]  J. Casanova,et al.  Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the beta1 subunit of the interleukin (IL)-12/IL-23 receptor. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[154]  S. Holland,et al.  Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[155]  Bertrand Joly,et al.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. , 2005, Haematologica.

[156]  L. Romani Immunity to fungal infections , 2004, Nature Reviews Immunology.

[157]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[158]  Fernando Rodrigues-Lima,et al.  Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. , 2004, Blood.

[159]  R. Hay,et al.  Deep dermatophytosis: rare infections or common, but unrecognised, complications of lymphatic spread? , 2004, Current opinion in infectious diseases.

[160]  P. Peterson,et al.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity , 2004, Clinical and experimental immunology.

[161]  Kohsuke Imai,et al.  Clinical course of patients with WASP gene mutations. , 2004, Blood.

[162]  R. Geha,et al.  The X-Linked Hyper-IgM Syndrome: Clinical and Immunologic Features of 79 Patients , 2003, Medicine.

[163]  C. Kortsik,et al.  Pleural Effusion due to Histoplasma capsulatum and Idiopathic CD4 Lymphocytopenia , 2003, Respiration.

[164]  E. Johnson,et al.  Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990–9) , 2001, Epidemiology and Infection.

[165]  J. Bertin,et al.  CARD9 Is a Novel Caspase Recruitment Domain-containing Protein That Interacts With BCL10/CLAP and Activates NF-κB* , 2000, The Journal of Biological Chemistry.

[166]  C Bos,et al.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. , 2000, Blood.

[167]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[168]  O. Boudghene-Stambouli,et al.  Maladie dermatophytique: hyperkératose exubérante avec cornes cutanées. , 1998 .

[169]  S. Holland,et al.  Aspergillus nidulans Infection in Chronic Granulomatous Disease , 1998, Medicine.

[170]  O. Boudghene-Stambouli,et al.  [Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns]. , 1998, Annales de dermatologie et de venereologie.

[171]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[172]  H. Dadi,et al.  Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[173]  Shinsei Minoshima,et al.  Positional cloning of the APECED gene , 1997, Nature Genetics.

[174]  J. Schreiber,et al.  Disseminated Histoplasma capsulatum in a patient with hyper IgM immunodeficiency. , 1994, Pediatrics.

[175]  N. Matsuo,et al.  Hyper‐IgM immunodeficiency with disseminated cryptococcosis , 1994, Acta paediatrica.

[176]  C. F. von Reyn,et al.  Idiopathic CD4+ T-lymphocytopenia--four patients with opportunistic infections and no evidence of HIV infection. , 1993, The New England journal of medicine.

[177]  Timo Niemi,et al.  Operation-oriented query language approach for recursive queries - Part 2. Prototype implementation and its integration with relational databases , 1992, Inf. Syst..

[178]  M. E. Peters,et al.  Esophageal histoplasmosis in a child with immunodeficiency with hyper-IgM. , 1991, AJR. American journal of roentgenology.

[179]  O. Boudghene-Stambouli,et al.  [Dermographic disease in Algeria. A new case and review of the literature]. , 1991, Annales de dermatologie et de venereologie.

[180]  O. Boudghene-Stambouli,et al.  [Trichophyton rubrum dermatophytic disease. A new case]. , 1989, Annales de dermatologie et de venereologie.

[181]  A. Fischer,et al.  Leukocyte adhesion deficiency: molecular basis and functional consequences. , 1988, Immunodeficiency reviews.

[182]  B. Liautaud,et al.  [Dermatophytic disease. Recent Algerian observations]. , 1984, Bulletin de la Societe de pathologie exotique et de ses filiales.

[183]  N. Okazaki,et al.  Trichophyton mentagrophytes granulomas. Unique systemic dissemination to lymph nodes, testes, vertebrae, and brain. , 1983, Archives of dermatology.

[184]  M. Gottlieb,et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. , 1981, The New England journal of medicine.

[185]  H. Masur,et al.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. , 1981, The New England journal of medicine.

[186]  J. Bennett,et al.  Chronic mucocutaneous candidiasis: model-building in cellular immunity. , 1971, Annals of internal medicine.

[187]  R. Kostmann Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in Man , 1956 .

[188]  R KOSTMANN,et al.  Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. , 1956, Acta paediatrica. Supplementum.

[189]  J. Sequeira A CASE OF TRICHOPHYTIC GRANULOMATA , 1912 .